# Sika Interplant Systems share price today (Sika Interplant Systems Ltd, NSE: SIKA) > Sika Interplant Systems share price today: ₹885.20 at the NSE close on 3 November 2026, down 24.6% in a year. Sika Interplant Systems (NSE: SIKA) is worth ₹1,876 crore, trades at a P/E of 54.1 and has closed between ₹823.25 and ₹1,218.30 over the past 52 weeks. > Sika Interplant Systems Ltd is reporting record margins. SIKA · Aerospace & Defence - Equipments · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/sika-interplant-systems-ltd Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms ## Key numbers - Business trend: Slowing from a peak, from the last 12 quarters - Price: ₹885.20 (−24.6% in a year) - P/E: 54.1× (higher than 80% of the last 11 years) - Revenue (Jun 2026): ₹42.9 Cr (−37.0% on a year ago) - Profit (Jun 2026): ₹8.4 Cr (−18.8% on a year ago) - Operating margin: 19.5% (+1.1 points on a year ago) - ROCE: 35%, FY26 - ROIC: 24.2%, against a 12.0% cost of capital: +12.2 points The main question: yearly earnings per share moved +43.8% while the share price moved −24.6%. ## What is the Sika Interplant Systems share price today? Sika Interplant Systems Ltd's share price was ₹885.20 at the close on 3 November 2026. It has been falling for 1 week. That is 11.9% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹823 and ₹1,218, and at that close it sat 16% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 8 weeks running. Over the last 11 years the share price moved +3,680% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 11 September 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Sika Interplant Systems this quarter? ## What are Sika Interplant Systems' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Sika Interplant Systems reported revenue of ₹42.9 crore, down 37.0% from ₹68.0 crore a year earlier, and a profit of ₹8.40 crore, down 18.8% from ₹10.3 crore. ### Sika Interplant Systems results: April to June 2026 against a year earlier | Measure | April to June 2026 | April to June 2025 | Change | | --- | --- | --- | --- | | Revenue | ₹42.9 crore | ₹68.0 crore | −37.0% | | Profit | ₹8.40 crore | ₹10.3 crore | −18.8% | | Earnings per share | ₹3.96 | ₹4.88 | −18.9% | | Operating margin | 19.5% | 18.4% | +1.1 points | The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.) ## What is the Sika Interplant Systems share price history? Sika Interplant Systems closed at ₹885.20 on 3 November 2026, down 24.6% from ₹1,174.30 a year earlier (31 October 2025) and up 545.1% over five years. Its highest weekly close since March 2016 was ₹1,476.90 on 20 June 2025. ### Sika Interplant Systems share price: then and now | When | Close | Change to 3 Nov 2026 | | --- | --- | --- | | 1 week ago · 23 Oct 2026 | ₹831.70 | +6.4% | | 1 month ago · 1 Oct 2026 | ₹1,012.65 | −12.6% | | 6 months ago · 30 Apr 2026 | ₹1,020.70 | −13.3% | | 1 year ago · 31 Oct 2025 | ₹1,174.30 | −24.6% | | 3 years ago · 3 Nov 2023 | ₹232.20 | +281.2% | | 5 years ago · 4 Nov 2021 | ₹137.21 | +545.1% | | 10 years ago · 4 Nov 2016 | ₹35.47 | +2,395.6% | | Earliest weekly close in our records · 11 Mar 2016 | ₹23.42 | +3,679.7% | | Highest weekly close since March 2016 · 20 Jun 2025 | ₹1,476.90 | −40.1% | | Lowest weekly close since March 2016 · 3 Jun 2016 | ₹23.39 | +3,684.5% | | 52-week high (weekly close) · 3 Jul 2026 | ₹1,218.30 | −27.3% | | 52-week low (weekly close) · 23 Jan 2026 | ₹823.25 | +7.5% | Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (557 weekly closes from 11 March 2016 to 3 November 2026.) ## What is the latest news on Sika Interplant Systems? 3 Nov 2026: Sika Interplant Systems closed at ₹885.20, up 6.4% on the week and down 12.6% on the month. 5 Aug 2026: ex-date for a dividend of ₹3.50 a share. ### Earlier - Results for April to June 2026: Revenue down 37.0% and profit down 18.8% on a year earlier. ## What dividend does Sika Interplant Systems pay? Sika Interplant Systems paid ₹3.50 a share in regular dividends in the 12 months to 4 November 2026 (1 payment), a yield of 0.40% at the ₹885.20 close on 3 November 2026. The last was a dividend of ₹3.50 a share, ex-date 5 August 2026. ### Sika Interplant Systems dividends since 1 April 2021 | Ex-date | Dividend per share | Type | | --- | --- | --- | | 5 Aug 2026 | ₹3.50 | Dividend | Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 0 of 5 Of the last 5 financial years, years with an NSE dividend record Yes. Sika Interplant Systems Ltd paid out 20% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years. (From the NSE corporate-actions record, read 4 November 2026.) ## Which stock lists is Sika Interplant Systems on? Sika Interplant Systems is on one of our India lists: Defence stocks. [Defence stocks Group on the list: Defence equipment and electronics](https://www.sectoralpha.in/sectors/aerospace-defence-equipments) ## Is Sika Interplant Systems profitable? Sika Interplant Systems Ltd earned ₹8.4 Cr of net profit in the Jun 2026 quarter, −18.8% on the same quarter a year earlier. Full-year FY26 profit was ₹36.0 Cr. Over 10 years profit has grown 33.5% a year on average. That is 19.6% of the quarter's revenue. The same quarter a year earlier earned ₹10.3 Cr. For the full year, FY26 profit was ₹36.0 Cr (+44.0% on the year before). Why profit moved: revenue changed −37.0% on a year earlier and the margin moved +1.1 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +14.4% and revenue +10.1%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. ## How much revenue does Sika Interplant Systems make, and is it growing? Sika Interplant Systems Ltd reported ₹42.9 Cr of revenue in the Jun 2026 quarter, −37.0% on the same quarter a year earlier. Over 10 years it has grown 17.5% a year on average. The last full year, FY26, came in at ₹211 Cr. The last four reported quarters add to ₹186 Cr. FY26 revenue was ₹211 Cr, +42.6% on the year before. Recent pace: the last four quarters grew +10.1% on average, against 17.5% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +0.4%, against +29.0% a year over the last 8 quarters (rolling over); profit over the last 12 months grew +9.8%, against +28.3% a year (rolling over). ## How much of every ₹100 of sales does Sika Interplant Systems keep? Sika Interplant Systems Ltd's operating margin was 19.5% in the Jun 2026 quarter, 1.1 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 13 years it has been between 7.0% and 21.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +1.1 percentage points on the year while gross margin changed +3.6 points. So the gain came mostly from the gross margin, which means input costs and prices charged. When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold. ## Is Sika Interplant Systems' profit turning into cash? Over the last 3 years, 94% of Sika Interplant Systems Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹47.0 Cr of operating cash against ₹36.0 Cr of profit. After ₹0.0 Cr of spending on assets, ₹47.0 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 94% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle. What to look at next: the bigger use of cash is spending on new assets, at 3.7× depreciation over three years. The next section checks what that spending is building. ## Where does Sika Interplant Systems' cash go? Sika Interplant Systems Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 6 days in FY26, up from 4 days in FY21. It spent ₹11.0 Cr on assets over the last 3 years. Customers take 18 days to pay, and stock sits for 3 days on average. At FY26 sales of ₹211 Cr, each day of that cycle ties up about ₹0.6 Cr, so roughly ₹3.0 Cr is tied up in the business at any time. FY26: customers took 18 days to pay and stock sat for 3 days, about 0.1 months of sales sitting as stock, for a full cycle of 6 days, longer than FY21's 4. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 3 days. Customers pay about 18 days after that. Suppliers are paid at 16 days. Together that makes the 6-day cycle. Spending on assets: ₹11.0 Cr over the last 3 years, against ₹3.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Sika Interplant Systems' P/E ratio, and how does it compare with its own history? Sika Interplant Systems Ltd's P/E is 54.1×, near the high end of its own history: higher than 80% of past readings. Its usual P/E (the middle reading) is 37.8×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +43.8% while the price moved −24.6%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved +45.2% a year; about +15.2% a year came from earnings growth and about +30.0 percentage points from the multiple (the market paying more); over 10 years the price moved +37.9% a year; about +34.9% a year came from earnings growth and about +3.0 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Sika Interplant Systems business getting better or worse? Sika Interplant Systems Ltd's business is slowing from a peak. Revenue, profit and EPS growth have slowed sharply (revenue growth from +60.5% at its peak to +0.4% now), while ROCE is still 29.7%. This is based on 12 quarters of 4 measures. Why it matters: slowing from a peak is where good stories often end quietly. ## How much does Sika Interplant Systems earn on its capital? Sika Interplant Systems Ltd earned a ROCE of 35% in FY26. That is up from a low of 5% in FY18. Its return on capital used (ROIC) is 12.2 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 17.1% net margin and 1.21× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 17.1% net margin × 1.21× asset turnover × 1.13× leverage (assets divided by equity) ≈ 23.4% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 24.2% − 12.0% = +12.2 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. A gap this wide means each rupee put back into the business creates more than a rupee of value. The 24.2% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 30.0%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Sika Interplant Systems have too much debt? Sika Interplant Systems Ltd had ₹0.0 Cr of borrowings against ₹155 Cr of equity in FY26, so its debt is 0.00× its equity. Its operating profit is 45 times its interest bill. Over 5 years borrowings went from ₹0.0 Cr to ₹0.0 Cr. Over the last 3 of those years it spent ₹11.0 Cr on assets. The spending on assets is being paid for from cash, not new debt. ## What is the Sika Interplant Systems shareholding pattern? No group of Sika Interplant Systems Ltd's owners changed its stake by a full percentage point over the last two years. Domestic institutions moved +0.1 points over the same period, to 0.1%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: +0.4 points over 8 quarters, to 3.2%; Domestic institutions: +0.1 points over 8 quarters, to 0.1%; Promoters: +0.0 points over 8 quarters, to 71.7%. ## How far is Sika Interplant Systems from balance-sheet trouble? For Sika Interplant Systems Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Sika Interplant Systems rank in its industry? 55.5 out of 100, rank 8 of 25 in Aerospace & Defence - Equipments, with 81% of the evidence available. Sika Interplant Systems Ltd scores 55.5 out of 100 against the 25 companies it is compared with in Aerospace & Defence - Equipments, ranking 8. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 13.1 + 21.7 + 12.9 + 7.8 = 55.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Sika Interplant Systems compared with? Sika Interplant Systems ranks 8 of 25 Aerospace & Defence - Equipments companies on the 4-Factor Sector Score, with 55.5 out of 100. 1. [Apollo Micro Systems Ltd](https://www.sectoralpha.in/stocks/apollo-micro-systems-ltd) APOLLO · turning · Most evidence points up · 100% evidence 70.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.9/35 · Revenue 77% · Profit 63.8% · Operating margin change 3 points · 100% evidence Capital efficiency 15.8/25 · ROCE 14.5% · Operating margin 29% · 100% evidence Valuation 9.2/20 · P/E 107× · PEG 1.7 · 100% evidence Relative strength 16.4/20 · Lead over its industry 10% · Lead over NIFTY 500 31% · 1 year 44.1% · 100% evidence · 4 of 12 weeks ahead Exact sum: 28.9 + 15.8 + 9.2 + 16.4 = 70.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [MTAR Technologies Ltd](https://www.sectoralpha.in/stocks/mtar-technologies-ltd) MTARTECH · breaking out · Most evidence points up · 90% evidence 70.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.3/35 · Revenue 53.5% · Profit 100% · Operating margin change 10.2 points · 100% evidence Capital efficiency 15.6/25 · ROCE 15.1% · Operating margin 23.2% · 100% evidence Valuation 7.4/20 · P/E 155× · PEG n/a · 50% evidence Relative strength 14.9/20 · Lead over its industry 18.6% · Lead over NIFTY 500 37.1% · 1 year 168.4% · 100% evidence · 5 of 12 weeks ahead Exact sum: 32.3 + 15.6 + 7.4 + 14.9 = 70.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Rossell Techsys Ltd](https://www.sectoralpha.in/stocks/rossell-techsys-ltd) ROSSTECH · leader · Evidence leans up · 79% evidence 64.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.5/35 · Revenue 82.9% · Profit 68.8% · Operating margin change 1.8 points · 88% evidence Capital efficiency 8.2/25 · ROCE 11.5% · Operating margin 14.4% · 100% evidence Valuation 8.8/20 · P/E 194× · PEG n/a · 15% evidence Relative strength 19.5/20 · Lead over its industry 28.7% · Lead over NIFTY 500 52.7% · 1 year 107.2% · 100% evidence · 11 of 12 weeks ahead Exact sum: 27.5 + 8.2 + 8.8 + 19.5 = 64 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Paras Defence and Space Technologies Ltd](https://www.sectoralpha.in/stocks/paras-defence-and-space-technologies-ltd) PARAS · breaking out · Evidence leans up · 82% evidence 63.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.4/35 · Revenue 41.5% · Profit 58.8% · Operating margin change 1 points · 95% evidence Capital efficiency 17.5/25 · ROCE 17.2% · Operating margin 29% · 76% evidence Valuation 8.7/20 · P/E 98.6× · PEG n/a · 50% evidence Relative strength 13.3/20 · Lead over its industry 17.1% · Lead over NIFTY 500 37.9% · 1 year 76.3% · 100% evidence · 10 of 12 weeks ahead Exact sum: 24.4 + 17.5 + 8.7 + 13.3 = 63.9 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 5. [Sigma Advanced System Ltd](https://www.sectoralpha.in/stocks/sigma-advanced-system-ltd) SIGMAADV · leader · Evidence leans up · 78% evidence 58.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.4/35 · Revenue 100% · Profit 20.3% · Operating margin change 307 points · 83% evidence Capital efficiency 9.8/25 · ROCE 11.7% · Operating margin 16% · 76% evidence Valuation 6.9/20 · P/E 102× · PEG n/a · 50% evidence Relative strength 15.0/20 · Lead over its industry 96.2% · Lead over NIFTY 500 116.7% · 1 year 318.8% · 100% evidence · 12 of 12 weeks ahead Exact sum: 26.4 + 9.8 + 6.9 + 15 = 58.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Azad Engineering Ltd](https://www.sectoralpha.in/stocks/azad-engineering-ltd) AZAD · leader · Evidence leans up · 89% evidence 57.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.0/35 · Revenue 29% · Profit 41.4% · Operating margin change 1 points · 88% evidence Capital efficiency 12.6/25 · ROCE 11.9% · Operating margin 37% · 100% evidence Valuation 9.0/20 · P/E 114× · PEG 1.94 · 65% evidence Relative strength 14.9/20 · Lead over its industry 4.2% · Lead over NIFTY 500 24.6% · 1 year 44.1% · 100% evidence · 12 of 12 weeks ahead Exact sum: 21 + 12.6 + 9 + 14.9 = 57.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Jaykay Enterprises Ltd](https://www.sectoralpha.in/stocks/jaykay-enterprises-ltd) JAYKAY · breaking out · Too little evidence to rank firmly · 51% evidence 56.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 34.3/43.75 · Revenue 100% · Profit 100% · Operating margin change 1.8 points · 83% evidence Capital efficiency 9.2/31.25 · ROCE 4.8% · Operating margin 14.2% · 76% evidence Valuation 12.9/25 · P/E 72.3× · PEG n/a · 15% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 34.3 + 9.2 + 12.9 = 56.4 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 8. Sika Interplant Systems Ltd this page SIKA · quiet · Evidence leans up · 81% evidence 55.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.1/35 · Revenue 0.5% · Profit 9.8% · Operating margin change 1.1 points · 88% evidence Capital efficiency 21.7/25 · ROCE 34.6% · Operating margin 19.5% · 100% evidence Valuation 12.9/20 · P/E 51.9× · PEG 1.01 · 100% evidence Relative strength 7.8/20 · Lead over its industry n/a · Lead over NIFTY 500 -9.8% · 1 year -27.7% · 25% evidence · 5 of 12 weeks ahead Exact sum: 13.1 + 21.7 + 12.9 + 7.8 = 55.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Data Patterns (India) Ltd](https://www.sectoralpha.in/stocks/data-patterns-indialtd) DATAPATTNS · quiet · Evidence leans up · 96% evidence 55.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.8/35 · Revenue 33.9% · Profit 24.2% · Operating margin change -5 points · 88% evidence Capital efficiency 21.3/25 · ROCE 21.9% · Operating margin 27% · 100% evidence Valuation 7.4/20 · P/E 78.7× · PEG 3.94 · 100% evidence Relative strength 5.5/20 · Lead over its industry -9.4% · Lead over NIFTY 500 8.8% · 1 year 38.5% · 100% evidence · 5 of 12 weeks ahead Exact sum: 20.8 + 21.3 + 7.4 + 5.5 = 55 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [High Energy Batteries (India) Ltd](https://www.sectoralpha.in/stocks/high-energy-batteries-indialtd) losing its lead · Evidence leans up · 72% evidence 53.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.9/35 · Revenue 1.5% · Profit -3.5% · Operating margin change 32.4 points · 95% evidence Capital efficiency 19.5/25 · ROCE 20.4% · Operating margin 28.1% · 95% evidence Valuation 11.8/20 · P/E 27.3× · PEG n/a · 50% evidence Relative strength 8.9/20 · Lead over its industry n/a · Lead over NIFTY 500 -2% · 1 year n/a · 25% evidence · 7 of 11 weeks ahead Exact sum: 12.9 + 19.5 + 11.8 + 8.9 = 53.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Hindustan Aeronautics Ltd](https://www.sectoralpha.in/stocks/hindustan-aeronautics-ltd) HAL · breaking out · Evidence leans up · 96% evidence 52.4 out of 100 Growth Capital Valuation Relative 12. [Dynamatic Technologies Ltd](https://www.sectoralpha.in/stocks/dynamatic-technologies-ltd) DYNAMATECH · breaking out · Evidence leans up · 79% evidence 50.9 out of 100 Growth Capital Valuation Relative 13. [Bharat Electronics Ltd](https://www.sectoralpha.in/stocks/bharat-electronics-ltd) BEL · turning · Evidence leans up · 100% evidence 50.8 out of 100 Growth Capital Valuation Relative 14. [Astra Microwave Products Ltd](https://www.sectoralpha.in/stocks/astra-microwave-products-ltd) ASTRAMICRO · quiet · Evidence leans down · 96% evidence 47.8 out of 100 Growth Capital Valuation Relative 15. [Zen Technologies Ltd](https://www.sectoralpha.in/stocks/zen-technologies-ltd) ZENTEC · turning · Evidence leans down · 60% evidence 47.6 out of 100 Growth Capital Valuation Relative 16. [Mishra Dhatu Nigam Ltd](https://www.sectoralpha.in/stocks/mishra-dhatu-nigam-ltd) MIDHANI · losing its lead · Evidence leans down · 96% evidence 42.5 out of 100 Growth Capital Valuation Relative 17. [AXISCADES Technologies Ltd](https://www.sectoralpha.in/stocks/axiscades-technologies-ltd) AXISCADES · breaking out · Evidence leans down · 89% evidence 41.6 out of 100 Growth Capital Valuation Relative 18. [BEML Ltd](https://www.sectoralpha.in/stocks/beml-ltd) BEML · breaking out · Evidence leans down · 88% evidence 40.9 out of 100 Growth Capital Valuation Relative 19. [Ideaforge Technology Ltd](https://www.sectoralpha.in/stocks/ideaforge-technology-ltd) IDEAFORGE · quiet · Evidence leans down · 71% evidence 39.8 out of 100 Growth Capital Valuation Relative 20. [Bharat Dynamics Ltd](https://www.sectoralpha.in/stocks/bharat-dynamics-ltd) BDL · basing · Evidence leans down · 96% evidence 35.6 out of 100 Growth Capital Valuation Relative 21. [Avantel Ltd](https://www.sectoralpha.in/stocks/avantel-ltd) AVANTEL · basing · Most evidence points down · 83% evidence 34.7 out of 100 Growth Capital Valuation Relative 22. [Aequs Ltd](https://www.sectoralpha.in/stocks/aequs-ltd) AEQUS · losing its lead · Too little evidence to rank firmly · 51% evidence 28.8 out of 100 Growth Capital Valuation Relative 23. [NIBE Ltd](https://www.sectoralpha.in/stocks/nibe-ltd) NIBE · quiet · Too little evidence to rank firmly · 53% evidence 27.8 out of 100 Growth Capital Valuation Relative 24. [DCX Systems Ltd](https://www.sectoralpha.in/stocks/dcx-systems-ltd) DCXINDIA · quiet · Most evidence points down · 61% evidence 23.8 out of 100 Growth Capital Valuation Relative 25. [Vinyas Innovative Technologies Ltd](https://www.sectoralpha.in/stocks/vinyas-innovative-technologies-ltd) VINYAS · turning · Too little evidence to rank firmly · 44% evidence 62.0 out of 100 Growth Capital Valuation Relative Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Aerospace & Defence - Equipments](https://www.sectoralpha.in/sectors/aerospace-defence-equipments), all 25 compared on one page. ## Which companies are close to Sika Interplant Systems in size? Sika Interplant Systems is the 22nd largest of 25 Aerospace & Defence - Equipments companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Ideaforge Technology, Jaykay Enterprises and Vinyas Innovative Technologies. Just below it: NIBE, DCX Systems and High Energy Batteries (India). ### Aerospace & Defence - Equipments companies close in size 1. [Ideaforge Technology Ltd](https://www.sectoralpha.in/stocks/ideaforge-technology-ltd) ₹3,125 crore 2. [Jaykay Enterprises Ltd](https://www.sectoralpha.in/stocks/jaykay-enterprises-ltd) ₹2,947 crore 3. [Vinyas Innovative Technologies Ltd](https://www.sectoralpha.in/stocks/vinyas-innovative-technologies-ltd) ₹1,866 crore 4. Sika Interplant Systems Ltd ₹1,799 crore 5. [NIBE Ltd](https://www.sectoralpha.in/stocks/nibe-ltd) ₹1,717 crore 6. [DCX Systems Ltd](https://www.sectoralpha.in/stocks/dcx-systems-ltd) ₹1,478 crore 7. [High Energy Batteries (India) Ltd](https://www.sectoralpha.in/stocks/high-energy-batteries-indialtd) ₹476 crore [All 25 Aerospace & Defence - Equipments companies, largest first](https://www.sectoralpha.in/sectors/aerospace-defence-equipments#all-companies) ### Companies close in size in other industries 1. [Windlas Biotech Ltd](https://www.sectoralpha.in/stocks/windlas-biotech-ltd) ₹1,808 crore · Pharma - API & CRAMS 2. [Schneider Electric President Systems Ltd](https://www.sectoralpha.in/stocks/schneider-electric-president-systems-ltd) ₹1,803 crore 3. Sika Interplant Systems Ltd ₹1,799 crore 4. [Advait Energy Transitions Limited](https://www.sectoralpha.in/stocks/advait-energy-transitions-limited) ₹1,798 crore · EPC 5. [Geojit Financial Services Ltd](https://www.sectoralpha.in/stocks/geojit-financial-services-ltd) ₹1,797 crore · Finance - Capital Markets - Brokers ## What else do people ask about Sika Interplant Systems? ### What is Sika Interplant Systems's share price today? Sika Interplant Systems Ltd's share price is ₹885.20, −24.6% over the past year. The whole company is worth ₹1,876 Cr on the market. In the last 52 weeks it traded between ₹823 to ₹1,218; today it is 16% of the way up from the low, 11.9% below its 200-day average (as of 3 November 2026). ### What were Sika Interplant Systems's latest quarterly results? Sika Interplant Systems Ltd reported revenue of ₹42.9 Cr and net profit of ₹8.4 Cr for the Jun 2026 quarter. Revenue fell 37.0% and profit fell 18.8% compared with a year earlier. Earnings per share were ₹3.96. The operating margin was 19.5%, 1.1 percentage points higher than a year earlier (as of 3 November 2026). ### What is Sika Interplant Systems's market cap? Sika Interplant Systems Ltd's market capitalisation is ₹1,876 Cr at a share price of ₹885.20. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Sika Interplant Systems performing? Sika Interplant Systems Ltd's share price has been falling for 1 weeks. In its latest quarter, revenue fell 37.0% and profit fell 18.8% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 8 weeks running (as of 3 November 2026). ### Will Sika Interplant Systems's share price go up? This page does not forecast Sika Interplant Systems Ltd's share price. What it shows instead: the share price is ₹885.20, and it has been falling for 1 weeks. Its P/E of 54.1× is higher than 80% of its own last 11 years (as of 3 November 2026). ### Where is Sika Interplant Systems in its business cycle? Sika Interplant Systems Ltd's FY26 operating margin was 21.0%, against a 13-year range of 7.0% to 21.0%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 19.5%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Sika Interplant Systems story? The main question: yearly earnings per share moved +43.8% while the share price moved −24.6%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Sika Interplant Systems a stock worth studying right now? What the numbers show: Sika Interplant Systems Ltd is reporting record margins. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists - Defence stocks: https://www.sectoralpha.in/sectors/aerospace-defence-equipments This is research, not advice. We’re not SEBI-registered.